Inhibition of endothelial cell activation by nitric oxide donors

被引:0
|
作者
Zampolli, A [1 ]
Basta, G [1 ]
Lazzerini, G [1 ]
Feelisch, M [1 ]
De Caterina, R [1 ]
机构
[1] CNR, Inst Clin Physiol, Lab Thrombosis & Vasc Res, I-56126 Pisa, Italy
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Because nitric oxide (NO) inhibits the expression of endothelial leukocyte adhesion molecules, NO-generating compounds have major therapeutic potential for use outside their classical indications. We report on the in vitro potential antiatherogenicity of two novel cysteine-containing NO donors, SP/W 3672, a fast spontaneous NO releaser, and its prodrug SP/W 5186, which liberates NO after bioactivation. The ability of these two compounds to inhibit monocyte adhesion and surface expression of endothelial adhesion molecules was evaluated and compared with that of other NO donors. SP/W 5186 and SP/W 3672 inhibited the adhesion of U937 monocytes to cultured human endothelial cells more potently than S-nitrosoglutathione (GSNO) or spermine NONOate, whereas nitroglycerin and isosorbide dinitrate were ineffective at comparable concentrations. A similar rank order of potency was found for the inhibition of expression of the adhesion molecules vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin as well as for major histocompatibility complex class II antigen expression. Estimated IC50 values for vascular cell adhesion molecule-1 were >400 muM for SP/W 4744 (control for SP/W 3672 lacking the cysteine moiety), 200 muM for GSNO and spermine NONOate, 80 muM for SP/W 3672, and 50 muM for SP/W 5186. Moreover, SP/W 5186 inhibited VCAM-1 mRNA levels more potently than GSNO. This effect was likely to be transcriptional because mRNA degradation was not affected. In conclusion, SP/W 3672 and SP/W 5186 are novel potent inhibitors of endothelial activation, and this effect appears to relate to their ability to liberate NO for prolonged periods of time, either spontaneously or after conversion to active hydrolytic products.
引用
收藏
页码:818 / 823
页数:6
相关论文
共 50 条
  • [31] Rapid activation of endothelial nitric oxide synthase by estrogen
    Shaul, PW
    STEROIDS, 1999, 64 (1-2) : 28 - 34
  • [32] PCSK9 inhibition decreases endothelial nitric oxide synthase activation in response to inflammatory conditions in endothelial cells
    Berti, G.
    Del Turco, S.
    Del Ry, S.
    Neglia, D.
    De Caterina, R.
    Caselli, C.
    EUROPEAN HEART JOURNAL, 2017, 38 : 447 - 447
  • [33] Intracellular localization and activation of endothelial nitric oxide synthase
    Feron, O
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (01): : 55 - 59
  • [34] Involvement of the proteasome in activation of endothelial nitric oxide synthase
    Govers, R
    de Bree, P
    Rabelink, TJ
    LIFE SCIENCES, 2003, 73 (17) : 2225 - 2236
  • [35] Nitric oxide promotes endothelial cell survival through the activation of the AKT protein kinase
    Kureishi, Y
    Walsh, K
    CIRCULATION, 2000, 102 (18) : 306 - 306
  • [36] Nitric oxide donors
    Yamamoto, T
    Bing, RJ
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 225 (03): : 200 - 206
  • [37] Effect of nitric oxide donors and synthase agonist peptides on endothelial cell uptake of L-arginine.
    Ogonowski, AA
    Kaesemeyer, WH
    Leibach, FG
    Ganapathy, V
    Andrews, B
    Caldwell, RW
    FASEB JOURNAL, 1998, 12 (04): : A442 - A442
  • [38] Effect of nitric oxide donors and synthase agonist peptides on endothelial cell uptake of L-arginine
    Ogonowski, AA
    Kaesemeyer, WH
    Leibach, FH
    Ganapathy, V
    Andrews, B
    Caldwell, RW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R413 - R413
  • [39] Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells - Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors
    Murohara, T
    Scalia, R
    Lefer, AM
    CIRCULATION RESEARCH, 1996, 78 (05) : 780 - 789
  • [40] Inhibition of increased sickle neutrophil adhesion to ICAM-1 by nitric oxide donors and activation of cGMP signaling
    Canalli, A.
    Conran, N.
    Saad, S. T. O.
    Costa, F. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 343 - 343